| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | -25.3% | — |
| R&D Expense | $13.8M | -34.3% | -13.4% |
| SG&A Expense | $6.5M | -14.7% | -11.2% |
| Operating Income | -$19.2M | +29.3% | +17.4% |
| Pre-tax Income | -$18.1M | +29.9% | +14.0% |
| Income Tax | $0 | -100.0% | +100.0% |
| Net Income | -$18.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.2M | -28.1% | -61.8% |
| Short-term Investments | $68.3M | +8.9% | -7.4% |
| Accounts Receivable | $820K | -24.7% | -91.8% |
| Current Assets | $98.2M | -4.3% | -35.7% |
| Total Assets | $161.6M | -10.5% | -33.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$60.9M | — | — |
| Capital Expenditures | $434K | — | — |
| Investing Cash Flow | $29.1M | — | — |
| Financing Cash Flow | $305K | — | — |
| Free Cash Flow | -$61.3M | — | — |
| +14.0% |
| EPS (Basic) | -$1.92 | +29.9% | +15.0% |
| EPS (Diluted) | -$1.92 | +29.9% | +15.0% |
| $14.6M |
| -14.8% |
| +7.6% |
| Total Liabilities | $62.5M | -4.3% | -2.2% |
| Stockholders' Equity | $99.0M | -14.0% | -44.9% |